Patents by Inventor Douglas Romer

Douglas Romer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12002586
    Abstract: Provided is a process, including: obtaining test data that quantifies a patient's cardiovascular status, the test data specifying patient attributes in a plurality of cardiovascular dimensions of the patient; determining a plurality of normalized differences between the test data and target criteria in each of the cardiovascular dimensions; determining predicted-effect vectors of each of a plurality of different classes of pharmaceuticals; determining an aggregate score for each respective class of pharmaceuticals among the different classes of pharmaceuticals based on values of the corresponding predicted-effect vectors; ranking the different classes of pharmaceuticals based on the aggregate scores; and outputting a recommended sequence of pharmaceuticals to administer.
    Type: Grant
    Filed: March 6, 2023
    Date of Patent: June 4, 2024
    Assignee: MediSync Inc.
    Inventors: Robert E. Matthews, Todd O'Connell, Douglas Romer
  • Publication number: 20230207130
    Abstract: Provided is a process, including: obtaining test data that quantifies a patient’s cardiovascular status, the test data specifying patient attributes in a plurality of cardiovascular dimensions of the patient; determining a plurality of normalized differences between the test data and target criteria in each of the cardiovascular dimensions; determining predicted-effect vectors of each of a plurality of different classes of pharmaceuticals; determining an aggregate score for each respective class of pharmaceuticals among the different classes of pharmaceuticals based on values of the corresponding predicted-effect vectors; ranking the different classes of pharmaceuticals based on the aggregate scores; and outputting a recommended sequence of pharmaceuticals to administer.
    Type: Application
    Filed: March 6, 2023
    Publication date: June 29, 2023
    Inventors: Robert E. Matthews, Todd O'Connel, Douglas Romer
  • Patent number: 11600388
    Abstract: Provided is a process, including: obtaining test data that quantifies a patient's cardiovascular status, the test data specifying patient attributes in a plurality of cardiovascular dimensions of the patient; determining a plurality of normalized differences between the test data and target criteria in each of the cardiovascular dimensions; determining predicted-effect vectors of each of a plurality of different classes of pharmaceuticals; determining an aggregate score for each respective class of pharmaceuticals among the different classes of pharmaceuticals based on values of the corresponding predicted-effect vectors; ranking the different classes of pharmaceuticals based on the aggregate scores; and outputting a recommended sequence of pharmaceuticals to administer.
    Type: Grant
    Filed: August 20, 2019
    Date of Patent: March 7, 2023
    Assignee: MediSync Inc.
    Inventors: Robert E. Matthews, Todd O'Connell, Douglas Romer
  • Publication number: 20210375455
    Abstract: Provided is a process that includes: obtaining, with an artificial intelligence (AI) application executed by a computer system, information about a current patient condition related to heart failure; inputting, with the computer system, at least some of the obtained information about the patient condition into respective pharmaceutical-specific models to obtain candidate classes of pharmaceuticals and their respective priority scores; inputting, with the computer system, into an expert system of the AI application, the candidate classes of pharmaceuticals and their respective priority scores and, in response, determining an updated prescription.
    Type: Application
    Filed: May 27, 2020
    Publication date: December 2, 2021
    Inventors: Robert E. Matthews, Charlie Hardtke, Douglas Romer, Todd O'Connell
  • Publication number: 20210057096
    Abstract: Provided is a process, including: obtaining test data that quantifies a patient's cardiovascular status, the test data specifying patient attributes in a plurality of cardiovascular dimensions of the patient; determining a plurality of normalized differences between the test data and target criteria in each of the cardiovascular dimensions; determining predicted-effect vectors of each of a plurality of different classes of pharmaceuticals; determining an aggregate score for each respective class of pharmaceuticals among the different classes of pharmaceuticals based on values of the corresponding predicted-effect vectors; ranking the different classes of pharmaceuticals based on the aggregate scores; and outputting a recommended sequence of pharmaceuticals to administer.
    Type: Application
    Filed: August 20, 2019
    Publication date: February 25, 2021
    Inventors: Robert E. Matthews, Todd O'Connell, Douglas Romer
  • Publication number: 20080303902
    Abstract: A method and system detects potential suspicious behavior in a monitored facility. The monitored facility includes at least one point of transaction terminal. Video content of an activity occurring at the monitored facility and transaction data relating to a transaction processed at the transaction terminal are collected. The video content is correlated with the transaction data to produce correlated data. A set of user-defined rules are applied to the correlated data. Responsive to identifying a match between the correlated data and at least one rule of the set of user-defined rules, the transaction is determined to be potentially suspicious.
    Type: Application
    Filed: June 9, 2008
    Publication date: December 11, 2008
    Applicant: Sensomatic Electronics Corporation
    Inventors: Kevin Douglas ROMER, Shuhai SHEN, Amber Marsel HEROLD